Cue Biopharma (CUE) Price to Book (2018 - 2026)

Cue Biopharma has disclosed Price to Book across 9 years of filings, most recently posting 71.45 for Q2 2026.

• In Q2 2026, Price to Book fell 17.05% year-over-year to 71.45; the TTM figure through Jun 2026 stood at 71.45 (down 17.05% YoY), while the FY2025 annual figure was 33.45, down 71.05% from the prior year.
• Price to Book came in at 71.45 for Q2 2026 at Cue Biopharma, up from 33.45 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 256.77 in Q1 2025 to a low of 33.45 in Q4 2025.
• Average Price to Book over 5 years is 90.21, with a median of 83.69 recorded in 2024.
• Year-over-year, Price to Book tumbled 78.39% in 2022 and jumped 204.72% in 2025.
• Over 5 years, Price to Book stood at 46.41 in 2022, then jumped by 117.29% to 100.83 in 2023, then advanced by 14.56% to 115.52 in 2024, then sank by 71.05% to 33.45 in 2025, then jumped by 113.61% to 71.45 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 71.45 in Q2 2026, 33.45 in Q4 2025, and 164.26 in Q3 2025.